T1	PROC 69 90	Estudio multinacional
T2	PROC 123 146	vacunación frente a VPH
T3	PROC 191 198	cribado
#1	AnnotatorNotes T3	C0220908; Screening procedure; Diagnostic Procedure | C1710031; Disease Screening; Diagnostic Procedure
T4	DISO 202 226	cáncer de cuello uterino
#2	AnnotatorNotes T4	C0007873; Uterine Cervical Neoplasm; Neoplastic Process | C0302592; Cervix carcinoma; Neoplastic Process | C4048328; cervical cancer; Neoplastic Process
T5	DISO 312 328	Cancer de cérvix
#3	AnnotatorNotes T5	C0007873; Uterine Cervical Neoplasm; Neoplastic Process | C0302592; Cervix carcinoma; Neoplastic Process | C4048328; cervical cancer; Neoplastic Process
T6	DISO 250 285	Tumor en el cérvix o cuello uterino
T7	ANAT 262 268	cérvix
#4	AnnotatorNotes T7	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T8	ANAT 271 285	cuello uterino
#5	AnnotatorNotes T8	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T9	ANAT 322 328	cérvix
#6	AnnotatorNotes T9	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T10	PROC 419 426	cribado
#7	AnnotatorNotes T10	C0220908; Screening procedure; Diagnostic Procedure | C1710031; Disease Screening; Diagnostic Procedure
T11	DISO 430 454	cáncer de cuello uterino
#8	AnnotatorNotes T11	C0007873; Uterine Cervical Neoplasm; Neoplastic Process | C0302592; Cervix carcinoma; Neoplastic Process | C4048328; cervical cancer; Neoplastic Process
T12	CHEM 1089 1104	inmunoglobulina
#9	AnnotatorNotes T12	C0021027; Immunoglobulins; Amino Acid, Peptide, or Protein · Immunologic Factor
T13	DISO 695 712	reacción alérgica
#10	AnnotatorNotes T13	C1527304; Allergic Reaction; Pathologic Function
T14	DISO 715 732	hipersensibilidad
#11	AnnotatorNotes T14	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T15	DISO 797 815	trastornos inmunes
T16	DISO 859 892	enfermedad aguda grave con fiebre
T17	DISO 913 922	infección
#12	AnnotatorNotes T17	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T18	DISO 937 997	infección respiratoria leve del tracto respiratorio superior
T19	ANAT 969 997	tracto respiratorio superior
T20	DISO 1003 1009	fiebre
#13	AnnotatorNotes T20	C0015967; Fever; Sign or Symptom
T21	CHEM 1107 1139	productos derivados de la sangre
#14	AnnotatorNotes T21	C0456388; Blood product; Pharmacologic Substance
T22	PROC 1317 1334	histerectomizadas
#15	AnnotatorNotes T22	C0020699; Hysterectomy; Therapeutic or Preventive Procedure
T23	ANAT 212 226	cuello uterino
#16	AnnotatorNotes T23	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T24	ANAT 440 454	cuello uterino
#17	AnnotatorNotes T24	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T25	CHEM 492 511	vacuna frente a VPH
T26	PROC 604 621	prueba de cribado
T27	CHEM 767 773	vacuna
#18	AnnotatorNotes T27	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T28	CHEM 851 857	vacuna
#19	AnnotatorNotes T28	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T29	CHEM 1037 1043	vacuna
#20	AnnotatorNotes T29	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	PROC 1071 1085	Administración
#21	AnnotatorNotes T30	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T31	ANAT 1133 1139	sangre
#22	AnnotatorNotes T31	C0005767; Blood; Body Substance
T32	CHEM 1210 1216	vacuna
#23	AnnotatorNotes T32	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T33	Date 13 17	2014
T34	LIVB 143 146	VPH
#24	AnnotatorNotes T34	C0021344; human papillomavirus; Virus
T35	LIVB 150 157	mujeres
#25	AnnotatorNotes T35	C0043210; Woman; Population Group
T36	Age 158 176	entre 25 y 45 años
T38	LIVB 355 370	Mujeres adultas
#26	AnnotatorNotes T38	C0043210; Woman; Population Group + C0001675; Adult; Age Group
T39	Age 371 387	entre 24-45 años
T40	Neg_cue 461 463	no
T41	LIVB 508 511	VPH
#27	AnnotatorNotes T41	C0021344; human papillomavirus; Virus
T42	LIVB 532 539	mujeres
#28	AnnotatorNotes T42	C0043210; Woman; Population Group
T43	Age 551 569	entre 30 y 45 años
T45	Neg_cue 596 603	ninguna
T46	Duration 625 646	los 5 años anteriores
T47	Neg_cue 894 901	excepto
T49	Duration 1143 1154	los 6 meses
T50	CONC 1193 1206	primera dosis
T51	PHYS 1221 1229	Embarazo
#29	AnnotatorNotes T51	C0032961; Pregnancy; Organism Function
T52	Date 1230 1236	actual
T53	PHYS 1250 1259	lactancia
#30	AnnotatorNotes T53	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T54	PHYS 1262 1270	embarazo
#31	AnnotatorNotes T54	C0032961; Pregnancy; Organism Function
T55	Duration 1283 1304	los próximos 12 meses
T56	LIVB 1309 1316	Mujeres
#32	AnnotatorNotes T56	C0043210; Woman; Population Group
T57	PHYS 808 815	inmunes
#33	AnnotatorNotes T57	C0020964; Immune response; Organ or Tissue Function
T58	ANAT 947 959	respiratoria
#34	AnnotatorNotes T58	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
A1	Population_data T38 Age
A2	Assertion T25 Negated
A3	Assertion T26 Negated
A4	Assertion T17 Negated
A5	Assertion T18 Negated
A6	Assertion T20 Negated
A7	Status T25 History_of
A8	Status T26 History_of
A9	Status T13 History_of
A10	Status T14 History_of
A11	Status T15 History_of
#35	AnnotatorNotes T6	C0007873; Uterine Cervical Neoplasm; Neoplastic Process | C0302592; Cervix carcinoma; Neoplastic Process | C4048328; cervical cancer; Neoplastic Process
#36	AnnotatorNotes T25	C1512511; Human Papilloma Virus Vaccine; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
#37	AnnotatorNotes T26	C0220908; Screening procedure; Diagnostic Procedure | C1710031; Disease Screening; Diagnostic Procedure
#38	AnnotatorNotes T19	C0041912; Upper Respiratory Infections; Disease or Syndrome
#39	AnnotatorNotes T52	C0521116; Current (present time); Temporal Concept 
R1	Experiences Arg1:T35 Arg2:T2	
R2	Has_Age Arg1:T35 Arg2:T36	
R3	Experiences Arg1:T35 Arg2:T3	
R4	Experiences Arg1:T35 Arg2:T4	
R5	Location_of Arg1:T23 Arg2:T4	
R6	Location_of Arg1:T7 Arg2:T6	
R7	Location_of Arg1:T8 Arg2:T6	
R8	Location_of Arg1:T9 Arg2:T5	
R9	Experiences Arg1:T56 Arg2:T22	
R11	Causes Arg1:T27 Arg2:T13	
R12	Causes Arg1:T27 Arg2:T14	
R13	Has_Age Arg1:T38 Arg2:T39	
R15	Location_of Arg1:T24 Arg2:T11	
R16	Experiences Arg1:T38 Arg2:T11	
R17	Negation Arg1:T40 Arg2:T25	
R18	Experiences Arg1:T38 Arg2:T25	
R19	Overlap Arg1:T26 Arg2:T46	
R20	Negation Arg1:T45 Arg2:T26	
R21	Has_Age Arg1:T42 Arg2:T43	
R22	Experiences Arg1:T42 Arg2:T26	
R23	Location_of Arg1:T19 Arg2:T18	
R24	Location_of Arg1:T58 Arg2:T18	
R25	Negation Arg1:T47 Arg2:T17	
T37	Quantifier_or_Qualifier 923 927	leve
#40	AnnotatorNotes T37	C2945599; Mild (qualifier value); Qualitative Concept
A12	Assertion T37 Negated
R26	Negation Arg1:T47 Arg2:T37	
R27	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T37	
T44	Quantifier_or_Qualifier 1010 1014	leve
A13	Assertion T44 Negated
#41	AnnotatorNotes T44	C2945599; Mild (qualifier value); Qualitative Concept
R29	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T44	
R30	Negation Arg1:T47 Arg2:T18	
R31	Negation Arg1:T47 Arg2:T20	
R32	Negation Arg1:T47 Arg2:T44	
R33	Used_for Arg1:T12 Arg2:T30	
R34	Used_for Arg1:T21 Arg2:T30	
R35	Overlap Arg1:T21 Arg2:T49	
R37	Overlap Arg1:T12 Arg2:T49	
R38	Has_Dose_or_Strength Arg1:T32 Arg2:T50	
R39	Before Arg1:T30 Arg2:T50	
R40	Overlap Arg1:T51 Arg2:T52	
T48	Observation 1262 1279	embarazo planeado
#42	AnnotatorNotes T48	C0032992; Pregnancy, Planned; Finding
R41	Overlap Arg1:T48 Arg2:T55	
R42	Before Arg1:T48 Arg2:T54	
T59	CONC 825 857	momento de administrar la vacuna
#43	AnnotatorNotes T59	C1115436; Date and time of vaccination; Temporal Concept (?)
R28	Overlap Arg1:T16 Arg2:T59	
R43	Experiences Arg1:T38 Arg2:T10	
#44	AnnotatorNotes T15	C1334156; Immune System and Related Disorders; Disease or Syndrome
#45	AnnotatorNotes R38	(?)
#46	AnnotatorNotes T50	C5236155; Date of First Dose; Temporal Concept
#47	AnnotatorNotes T2	C3160904; Human papilloma virus immunization; Therapeutic or Preventive Procedure
A14	Experiencer T35 Patient
A15	Experiencer T38 Patient
A16	Experiencer T42 Patient
A17	Status T54 Future
A18	Experiencer T56 Patient
